CAS RN: 30195-30-3
Ro 5-3335
Product Availability
Choose a grade to view its available package options.
5 package records 4 with current stock 1 grade group
Grade
98+% (5)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250421
100mg
In stock
Shanghai Inquiry
Batchno.20260101
10mg
In stock
Shanghai Inquiry
Batchno.20250503
250mg
Out of stock
Inquiry
Batchno.20250220
50mg
In stock
Shanghai Inquiry
Batchno.20250409
5mg
In stock
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 30195-30-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
≥95%
0
Out of Stock
Shanghai
Inquiry
30195-30-3 / 7-chloro-5-(1H-pyrrol-2-yl)-1,3-dihydro-1,4-benzodiazepin-2-one
Standard CAS: 30195-30-3
Multi CAS: No
Basic Information
copy
CAS
30195-30-3 copy
Multi CAS
No copy
Molecular Formula
C13H10CLN3O copy
Molecular Weight
259.690000 copy
Exact Mass
259.051240 copy
InChI
InChI=1S/C13H10ClN3O/c14-8-3-4-10-9(6-8)13(11-2-1-5-15-11)16-7-12(18)17-10/h1-6,15H,7H2,(H,17,18) copy
InChIKey
XWNMORIHKRROGW-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
18 copy
Aromatic heavy atom count
11 copy
Fraction Csp3
0.08 copy
Rotatable bonds
1 copy
H-bond acceptors
2 copy
H-bond donors
2 copy
Molar refractivity
71.38 copy
TPSA
57.25 copy
LogP / Solubility
WLOGP
2.46 copy
MLOGP
2.17 copy
XLogP3
1.5 copy
Consensus LogP
2.04 copy
Log S (ESOL)
-3.38 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.46 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.51 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.56 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy